Molly C. Dwyer-White, M.P.H., named managing director of Elizabeth Weiser Caswell Diabetes Institute
Molly C. Dwyer-White, M.P.H., has been named the next managing director of the Elizabeth Weiser Caswell Diabetes Institute (CDI), effective Dec. 13.
Dwyer-White will take over from Dorene Markel, M.S., MHSA, to has filled in as managing director for the past few months.
Dwyer-White comes to CDI with many years of experience in supporting major, multi-disciplinary teams and research endeavors, especially in translational research arenas important for patients and communities. Most recently, she served as the Michigan Health and Hospital Association’s (MHA) vice president of safety and quality and the MHA Keystone Center’s executive director. In this dual role, Dwyer-White developed and executed strategies to drive improvements in quality, safety and experience across the state through evidence-based best practices, with special focus on addressing health and health care disparities. Prior to the MHA, she served as the director for the Office of Patient Experience at Michigan Medicine, where she provided leadership on systemwide initiatives to improve the patient and family experience.
Dwyer-White has extensive experience working to support diabetes and metabolic research, education and care gained at U-M during her previous work with the Brehm Center, where she played important roles in accelerating the search for ways to prevent and cure diabetes and its complications.